ACADIA Pharmaceuticals Inc.

Q4 2020 13F Holders

Symbol
ACAD
CUSIP
004225108
Type
Equity
Class
COM
Num filings
328
Total reported value, excl. options
$7.93 B
Manager Report Date Value ($000) Shares Option Type